tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Katherine Breedis, 7 are a BUY (100%).
Analyst Katherine Breedis, carries an average stock price target met ratio of 77.78% that have a potential upside of 71.16% achieved within 1001 days. Previously, Katherine Breedis worked at STIFEL.
Katherine Breedis’s has documented 14 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VYGR, Voyager Therapeutics at 28-Jul-2017.
Analyst best performing recommendations are on SAGE (SAGE THERAPEUTIC).
The best stock recommendation documented was for VYGR (VOYAGER THERAPEUTICS) at 7/28/2017. The price target of $20 was fulfilled within 63 days with a profit of $10.91 (120.02%) receiving and performance score of 19.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Feb-2026
$172
$15.49 (9.90%)
$162
Hold Since 01-Feb-2023
$126
$-30.51 (-19.49%)
$123
14 days ago
(07-Oct-2026)
91/109 (83.49%)
$-21.1 (-14.34%)
1574
Buy Since 20-Apr-2025
$155
$-1.51 (-0.96%)
$155
14 days ago
(07-Oct-2026)
34/35 (97.14%)
$7.9 (5.37%)
309
Buy Since 23-Nov-2025
$158
$1.49 (0.95%)
$156
15 days ago
(06-Oct-2026)
7/8 (87.5%)
$11.15 (7.59%)
106
Buy Since 27-Oct-2022
$170
$13.49 (8.62%)
$150
15 days ago
(06-Oct-2026)
10/11 (90.91%)
$23.15 (15.76%)
273
